Hair loss in perimenopause and menopause

Here's what's actually happening

Hair loss affects more than half of women going through the menopausal transition. It tends to show up gradually — less density overall, slower growth, finer texture, thinning at the crown and along the part — which makes it easy to dismiss as normal aging. It is age-related, but the hormonal component is significant and specific.

Hair follicles have estrogen receptors. They are designed to respond to estrogen, and estrogen supports the growth phase of the hair cycle — keeping follicles active, promoting blood flow to the scalp, and helping maintain hair thickness and caliber. When estrogen declines, follicles get less of that support. The growth phase shortens. Hairs spend more time in the resting and shedding phases. Over time, individual follicles can miniaturize — producing progressively finer, shorter hairs until they produce very little at all.

The androgen piece also matters, even in women who don't have high testosterone levels. As estrogen declines, the balance between estrogen and androgens shifts. In follicles that are genetically sensitive to androgens, this shift can accelerate the miniaturization process. Interestingly, most women with menopausal hair loss don't have elevated androgens — it's the relative change in ratio that matters, not necessarily high levels. Recent research also points to elevated LH — the hormone that rises sharply during perimenopause — as a possible contributor to follicle stress and hair loss.

In perimenopause vs. menopause

The menopausal transition can actually begin affecting hair up to ten years before the final period, as hormonal fluctuations start to disrupt the hair cycle. Women in perimenopause often notice increased shedding first — more hair coming out during washing or brushing — before the overall thinning becomes visible.

After menopause, without treatment, hair loss tends to continue progressing. The longer estrogen has been low, the more follicles have had time to shrink and go quiet. This is one of the reasons starting treatment earlier — when more follicles are still active — tends to produce better outcomes than waiting years.

What this means for your care

Here we want to be honest with you: hormone therapy is not a proven treatment for hair loss, and it is not something we would prescribe for hair loss alone. The research on estrogen and hair growth is promising but not yet definitive — and topical minoxidil, which is FDA-approved for female-pattern hair loss, has stronger evidence for slowing loss and stimulating regrowth than estrogen does.

That said, when women are on hormone therapy for their other symptoms — hot flashes, sleep, mood, joint pain — many notice improvement in hair quality, growth rate, and shedding as a secondary benefit. Estrogen supports the metabolic and vascular health of the follicle, and restoring that environment can help. If you are on combined therapy, the type of progesterone matters. Micronized progesterone — the kind we use — is preferred over certain synthetic versions, some of which can behave more like testosterone in the body and potentially make hair loss worse.

If hair loss is significantly bothering you, it is worth a dedicated conversation. Minoxidil — applied topically or taken in low oral doses — is the most established option and is commonly used alongside hormone therapy. Other treatments including spironolactone, finasteride, and procedural options like platelet-rich plasma exist and may be appropriate depending on your situation.